These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18285426)

  • 1. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
    Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
    J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
    Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.
    Patil S; Perry A; Maccollin M; Dong S; Betensky RA; Yeh TH; Gutmann DH; Stemmer-Rachamimov AO
    Brain Pathol; 2008 Oct; 18(4):517-9. PubMed ID: 18422762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
    Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
    Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
    Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
    BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis: an evolving paradigm].
    Dereure O
    Ann Dermatol Venereol; 2009 Mar; 136(3):296-7. PubMed ID: 19328320
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
    van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
    Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.
    Paganini I; Capone GL; Vitte J; Sestini R; Putignano AL; Giovannini M; Papi L
    J Neurooncol; 2018 Mar; 137(1):33-38. PubMed ID: 29230670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
    Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
    Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
    Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
    J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.
    Bacci C; Sestini R; Provenzano A; Paganini I; Mancini I; Porfirio B; Vivarelli R; Genuardi M; Papi L
    Neurogenetics; 2010 Feb; 11(1):73-80. PubMed ID: 19582488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1.
    Swensen JJ; Keyser J; Coffin CM; Biegel JA; Viskochil DH; Williams MS
    J Med Genet; 2009 Jan; 46(1):68-72. PubMed ID: 19124645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
    Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
    Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
    Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
    Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.
    Piotrowski A; Xie J; Liu YF; Poplawski AB; Gomes AR; Madanecki P; Fu C; Crowley MR; Crossman DK; Armstrong L; Babovic-Vuksanovic D; Bergner A; Blakeley JO; Blumenthal AL; Daniels MS; Feit H; Gardner K; Hurst S; Kobelka C; Lee C; Nagy R; Rauen KA; Slopis JM; Suwannarat P; Westman JA; Zanko A; Korf BR; Messiaen LM
    Nat Genet; 2014 Feb; 46(2):182-7. PubMed ID: 24362817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
    Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
    Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
    Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
    Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.
    Zhang K; Lin JW; Wang J; Wu X; Gao H; Hsieh YC; Hwu P; Liu YR; Su L; Chiou HY; Wang D; Yuan YC; Whang-Peng J; Chiu WT; Yen Y
    Genet Med; 2014 Oct; 16(10):787-92. PubMed ID: 24763291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.